Peter Hersey
Impact in
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Melanoma and MAPK Pathways 61
- Cell death mechanisms and regulation 45
- Immunology 161
- Immunotherapy and Immune Responses 116
- Immune Cell Function and Interaction 31
- Co-authors
- Xu Dong Zhang (79 shared papers)John F. Thompson (23 shared papers)William H. McCarthy (31 shared papers)Wayne Thomas (9 shared papers)Richard A. Scolyer (25 shared papers)Susan Gillespie (12 shared papers)Richard Kefford (30 shared papers)C. Gray (8 shared papers)
- Journals
- Journal of Clinical Oncology (37 papers)International Journal of Cancer (28 papers)Melanoma Research (16 papers)Clinical Cancer Research (15 papers)British Journal of Cancer (14 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Peter Hersey
358 papers receiving 20.6k citations
Peter Hersey's Hit Papers
Peers
Comparison fields: 5 of 153
- Oncology 9.2k
- Immunology 6.8k
- Molecular Biology 10.3k
- Cancer Research 1.9k
- Immunology and Allergy 593
Countries citing papers authored by Peter Hersey
This map shows the geographic impact of Peter Hersey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hersey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hersey more than expected).
Fields of papers citing papers by Peter Hersey
This network shows the impact of papers produced by Peter Hersey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hersey. The network helps show where Peter Hersey may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hersey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 362 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved survival with MEK Inhibition in BRAF-mutated melanoma for the METRIC Study Group Hit paper breakdown → | 2012 | 1110 |
| 2 | Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 Hit paper breakdown → | 2019 | 659 |
| 3 | Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma Hit paper breakdown → | 2011 | 525 |
| 4 | Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group Hit paper breakdown → | 2006 | 478 |
| 5 | Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma Hit paper breakdown → | 2009 | 446 |
| 6 | Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. | 1999 | 358 |
| 7 | 2017 | 346 | |
| 8 | 2014 | 340 | |
| 9 | 2018 | 332 | |
| 10 | 1998 | 275 | |
| 11 | 1979 | 238 | |
| 12 | 2011 | 228 | |
| 13 | 1997 | 218 | |
| 14 | 1994 | 214 | |
| 15 | 2000 | 200 | |
| 16 | 2015 | 195 | |
| 17 | 2004 | 193 | |
| 18 | 2000 | 187 | |
| 19 | 2010 | 184 | |
| 20 | Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. | 2001 | 178 |
About Peter Hersey
Peter Hersey is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 362 papers that have together received 21.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (116 papers), Melanoma and MAPK Pathways (61 papers), CAR-T cell therapy research (58 papers), Cancer Immunotherapy and Biomarkers (50 papers), Cutaneous Melanoma Detection and Management (45 papers), Cell death mechanisms and regulation (45 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Immune Cell Function and Interaction (31 papers). The work is most often cited by research in Oncology (9.2k citations), Immunology (6.8k citations), Molecular Biology (10.3k citations), Cancer Research (1.9k citations) and Immunology and Allergy (593 citations). Peter Hersey has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Xu Dong Zhang, John F. Thompson, William H. McCarthy, Wayne Thomas, Richard A. Scolyer, Susan Gillespie, Richard Kefford, C. Gray, Caroline Robert and Chen Chen Jiang. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer, Melanoma Research, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.